doi: 10.1016/0192-0561(87)90061-0.
Effects of adriamycin, 4-hydroperoxycyclophosphamide and ASTA Z 7557 (INN mafosfamide) on the release of IL-2 and IL-1 in vitro
- PMID: 3497116
- DOI: 10.1016/0192-0561(87)90061-0
Item in Clipboard
Effects of adriamycin, 4-hydroperoxycyclophosphamide and ASTA Z 7557 (INN mafosfamide) on the release of IL-2 and IL-1 in vitro
Int J Immunopharmacol.
1987.
Abstract
Adriamycin (ADR), 4-hydroperoxycyclophosphamide (4-OOHCYP) and the new cyclophosphamide derivative AZ 7557 (AZ) were tested for their effects on the release of the Interleukins IL-2 and IL-1 from rat spleen cells and peritoneal exudate macrophages respectively. ADR was found to enhance IL-2 release and less effectively IL-1 release. 4-OOHCYP and AZ were found to inhibit IL-2 release but had no effect on IL-1 production. It is suggested that the modulation of IL-2 levels by these drugs is unlikely to be mediated by their effects on IL-1.
Similar articles
-
Enhancement of interleukin-2 release in rats by treatment with bleomycin and adriamycin in vivo.Cancer Immunol Immunother. 1987;25(3):245-9. doi: 10.1007/BF00199154. Cancer Immunol Immunother. 1987. PMID: 2445487 Free PMC article.
-
Effect of anticancer agents neothramycin, aclacinomycin, FK-565 and FK-156 on the release of interleukin-2 and interleukin-1 in vitro.Cancer Immunol Immunother. 1989;28(2):87-92. doi: 10.1007/BF00199107. Cancer Immunol Immunother. 1989. PMID: 2783891 Free PMC article.
-
Potentiation of release of interleukin-2 by bleomycin.Immunopharmacology. 1986 Oct;12(2):127-34. doi: 10.1016/0162-3109(86)90038-x. Immunopharmacology. 1986. PMID: 2429940
-
Effect of anticancer drugs on the release of interferon gamma in vitro.Cancer Immunol Immunother. 1989;30(4):213-8. doi: 10.1007/BF01665007. Cancer Immunol Immunother. 1989. PMID: 2480848 Free PMC article.
-
Immunomodulation by adriamycin.Sci Rep Res Inst Tohoku Univ Med. 1985 Dec;32(1-4):10-3. Sci Rep Res Inst Tohoku Univ Med. 1985. PMID: 3915832 Review. No abstract available.
Cited by
-
Effect of anticancer drugs on the release of tumour necrosis factor in vitro.Cancer Immunol Immunother. 1990;30(6):363-6. doi: 10.1007/BF01786886. Cancer Immunol Immunother. 1990. PMID: 2302726 Free PMC article.
-
Fatal exacerbation of paraneoplastic systemic sclerosis after neoadjuvant chemotherapy in a breast cancer patient.Clin Rheumatol. 2004 Jun;23(3):269-71. doi: 10.1007/s10067-004-0875-x. Epub 2004 Apr 14. Clin Rheumatol. 2004. PMID: 15168161
-
Potentiation of interleukin-2 release by anti cancer drugs.Agents Actions. 1989 Jan;26(1-2):156-7. doi: 10.1007/BF02126591. Agents Actions. 1989. PMID: 2469319 No abstract available.
-
CP-115,953 stimulates cytokine production by lymphocytes.Antimicrob Agents Chemother. 1995 Feb;39(2):476-83. doi: 10.1128/AAC.39.2.476. Antimicrob Agents Chemother. 1995. PMID: 7726518 Free PMC article.
-
Enhancement of interleukin-2 release in rats by treatment with bleomycin and adriamycin in vivo.Cancer Immunol Immunother. 1987;25(3):245-9. doi: 10.1007/BF00199154. Cancer Immunol Immunother. 1987. PMID: 2445487 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
